Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2018
Price : $35 *
At a glance
- Drugs Nelfinavir (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- Acronyms NISLE
- 31 Aug 2018 Biomarkers information updated
- 25 Jul 2018 Status changed from recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.